Literature DB >> 12243824

Analysis of prognostic factors for T(1)N(0)M(0) glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy Of Medical Sciences.

Jing Jin1, Zhongxing Liao, Li Gao, Xiaodong Huang, Guozhen Xu.   

Abstract

PURPOSE: To analyze the prognostic factors for early-stage glottic cancer (T(1)N(0)M(0)) treated with radiotherapy alone. METHODS AND MATERIALS: Between 1958 and 1994, 238 patients (220 male) with T(1)N(0)M(0) (UICC 1997) squamous cell carcinoma of the glottis were treated with 6- or 8 MV X-ray or 60Co radiation in parallel-opposed fields (median size: 22.5 cm(2)) over a median of 52 days to a median dose of 68 Gy. Locoregional control (LC) and overall survival (OS) were estimated by the Kaplan-Meier method. Log-rank and Cox regression analyses were used to identify prognostic factors.
RESULTS: The median follow-up time was 127 months (range: 4-410 months). Five- and 10-year OS rates were 84.0% and 74.9%. The 5-year LC rate was 82.2%. Forty-four patients had recurrent disease (41 locally, 2 in cervical lymph nodes, 1 lost to follow-up); 23 had second malignancies. On multivariate analysis, unfavorable prognostic factors for OS were age >65 years (p < 0.001) and second malignancy (p < 0.001). Unfavorable prognostic factors for LC were bulky tumor (p = 0.023), anterior commissure involvement (p = 0.024), and decrease in hemoglobin during treatment (p = 0.025).
CONCLUSIONS: Radiotherapy alone provides good control of early-stage glottic cancer. Bulky tumor, anterior commissure involvement, and decreasing hemoglobin are negative prognostic factors for LC.

Entities:  

Mesh:

Year:  2002        PMID: 12243824     DOI: 10.1016/s0360-3016(02)02920-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

1.  Outcome of radiotherapy in T1 glottic carcinoma: a population-based study.

Authors:  Elisabeth Victoria Sjögren; Ruud G J Wiggenraad; Saskia Le Cessie; Simone Snijder; Jaqueline Pomp; Robert Jan Baatenburg de Jong
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10-07       Impact factor: 2.503

Review 2.  Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review.

Authors:  Federico Maria Gioacchini; Michele Tulli; Shaniko Kaleci; Stefano Bondi; Mario Bussi; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-19       Impact factor: 2.503

3.  Survival analysis of laryngeal carcinoma without laryngectomy, radiotherapy, or chemotherapy.

Authors:  Qiong Yu; Xueyuan Zhang; Changyou Ji; Hua Yang; Minghua Gao; Suling Hong; Guohua Hu
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-21       Impact factor: 2.503

Review 4.  Primary treatment of the anterior vocal commissure squamous carcinoma.

Authors:  Patrick J Bradley; Alessandra Rinaldo; Carlos Suárez; Ashok R Shaha; C René Leemans; Johannes A Langendijk; Snehal G Patel; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-08-15       Impact factor: 2.503

5.  Radiotherapy with or without chemotherapy for patients with T1-T2 glottic carcinoma: retrospective analysis.

Authors:  Naoki Hirasawa; Yoshiyuki Itoh; Shunichi Ishihara; Seiji Kubota; Junji Itoh; Yasushi Fujimoto; Tsutomu Nakashima; Shinji Naganawa
Journal:  Head Neck Oncol       Date:  2010-07-30

6.  Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons.

Authors:  Chi-Chung Tong; Kwok-Hung Au; Roger K C Ngan; Sin-Ming Chow; Foon-Yiu Cheung; Yiu-Tung Fu; Joseph S K Au; Stephen C K Law
Journal:  Radiat Oncol       Date:  2011-05-21       Impact factor: 3.481

7.  A multicenter survey of stage T1 glottic cancer treated with radiotherapy delivered in 2.25-Gy fractions in clinical practice: An initial 5-year analysis.

Authors:  Yoshiyuki Itoh; Seiji Kubota; Mariko Kawamura; Yoshihito Nomoto; Takayuki Murao; Kouji Yamakawa; Shunichi Ishihara; Naoki Hirasawa; Akiko Asano; Shigeo Yanagawa; Shinji Naganawa
Journal:  Nagoya J Med Sci       Date:  2016-12       Impact factor: 1.131

Review 8.  Involvement of the Anterior Commissure in Early Glottic Cancer (Tis-T2): A Review of the Literature.

Authors:  Martine Hendriksma; Elisabeth V Sjögren
Journal:  Cancers (Basel)       Date:  2019-08-23       Impact factor: 6.639

9.  Multi-institutional analysis of early glottic cancer from 2000 to 2005.

Authors:  Naoki Hirasawa; Yoshiyuki Itoh; Shinji Naganawa; Shunichi Ishihara; Kazunori Suzuki; Kazuyuki Koyama; Takayuki Murao; Akiko Asano; Yoshihito Nomoto; Yoshimi Horikawa; Masahiro Sasaoka; Yasunori Obata
Journal:  Radiat Oncol       Date:  2012-08-01       Impact factor: 3.481

10.  Early glottic cancer treatment with concurrent chemoradiotherapy with once-daily orally administered S-1.

Authors:  Yuuki Takase; Yoshiyuki Itoh; Kazuhiro Ohtakara; Mariko Kawamura; Junji Ito; Yumi Oie; Tamami Ono; Yutaro Sasaki; Ayumi Nishida; Shinji Naganawa
Journal:  Nagoya J Med Sci       Date:  2021-05       Impact factor: 1.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.